Advisory - BlackOxygen Organics recalls fulvic acid tablets and powder due to potential health risks
OTTAWA, ON, Sept. 23, 2021 /CNW/ -
Summary
Product: BlackOxygen Tablets (NPN 80106662) and BlackOxygen Organics Powder (NPN 80097385) (licensed to NuWTR).
Issue: BlackOxygen Organics is recalling all lots of these products due to potential health risks which may be higher for children, adolescents, and pregnant or breastfeeding women. The products are being promoted in ways and for uses that have not been evaluated and authorized by Health Canada.
What to do: Stop taking these products. Do not administer the products to children or adolescents. If you or your child or adolescent have taken either of these products and have health concerns, speak to a healthcare provider.
Issue BlackOxygen Organcs is recalling all lots of BlackOxygen Tablets (NPN 80106662) and BlackOxygen Organics Powder (NPN 80097385) due to potential health risks.
These products are being marketed as fulvic acid supplement(s); however, this use and the quantity of fulvic acid provided by these products has not been evaluated or authorized by Health Canada.
There is limited information to support the safety of fulvic acid when consumed at the quantities found in these products, especially by children and adolescents, and by pregnant or breastfeeding women. The safety of long-term use is also unknown.
The powder product is also being marketed for use on the skin, which has not been evaluated by Health Canada.
The company has stopped sale and is recalling these products. Health Canada is monitoring the recall. If additional safety information
Affected products
BlackOxygen Tablets (NPN 80106662)
BlackOxygen Organics Powder (NPN 80097385)
What you should do
Stop taking these products. Do not administer the products to children or adolescents.
If you or your child or adolescent have taken either of these products and have health concerns, speak to a healthcare provider.
Contact BlackOxygen Organics if you have questions about the recall by email at [email protected].
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community. Aspire Health experienced a data security incident that may have involved personal and...
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...
Summary
Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...